A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro

Journal of Medicinal Chemistry

Volumn 56, Issue 3, 2013, Pages 796-806

  Zhou, Linna ^a   Stewart, Gavin ^a   Rideau, Emeline ^a   Westwood, Nicholas J ^a   Smith, Terry K ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 NITRO 2 FURANCARBOXYLAMIDE DERIVATIVE; ANTITRYPANOSOMAL AGENT; FURAN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; TRYPANOSOMA BRUCEI;

AMIDES; ANIMALS; HELA CELLS; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

EID: 84873904852     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm301215e     Document Type: Article

References (43)

1. Trypanosomiasis, African; World Health Organization: Geneva, 2012; http://www.who.int/topics/trypanosomiasis-african/en/ (Accessed 10 August 2012).
2. Priotto, G.; Kasparian, S.; Mutombo, W.; Ngouama, D.; Ghorashian, S.; Arnold, U.; Ghabri, S.; Baudin, E.; Buard, V.; Kazadi-Kyanza, S.; Ilunga, M.; Mutangala, W.; Pohlig, G.; Schmid, C.; Karunakara, U.; Torreele, E.; Kande, V. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial Lancet 2009, 374, 56-64
3. Steverding, D. The development of drugs for treatment of sleeping sickness: a historical review Parasites Vectors 2010, 3, 15
4. Delespaux, V.; de Koning, H. P. Drugs and drug resistance in African trypanosomiasis Drug Resistance Updates 2007, 10, 30-50
5. Baker, N.; Alsford, S.; Horn, D. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6 Mol. Biochem. Parasitol. 2011, 176, 55-57
6. Barry, C. E., III; Boshoff, H. I.; Dowd, C. S. Prospects for clinical introduction of nitroimidazole antibiotics for the treatment of tuberculosis Curr. Pharm. Des. 2004, 10, 3239-3262
7. Ginsberg, A. M.; Laurenzi, M. W.; Rouse, D. J.; Whitney, K. D.; Spigelman, M. K. Safety, tolerability, and pharmacokinetics of PA-824 in healthy subjects Antimicrob. Agents Chemother. 2009, 53, 3720-3725
8. Nuermberger, E.; Tyagi, S.; Tasneen, R.; Williams, K. N.; Almeida, D.; Rosenthal, I.; Grosset, J. H. Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis Antimicrob. Agents Chemother. 2008, 52, 1522-1524
9. Sokolova, A. Y.; Wyllie, S.; Patterson, S.; Oza, S. L.; Read, K. D.; Fairlamb, A. H. Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis Antimicrob. Agents Chemother. 2010, 54, 2893-2900
10. Wilkinson, S. R.; Taylor, M. C.; Horn, D.; Kelly, J. M.; Cheeseman, I. A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 5022-5027
11. Hall, B. S.; Bot, C.; Wilkinson, S. R. Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites J. Biol. Chem. 2011, 286, 13088-13095
12. Castro, J. A.; deMecca, M. M.; Bartel, L. C. Toxic Side Effects of Drugs Used to Treat Chagas' Disease (American Trypanosomiasis) Human Exp. Toxicol. 2006, 25, 471-479
13. Rodriques Coura, J.; de Castro, S. L. A critical review on Chagas disease chemotherapy Mem. Inst. Oswaldo Cruz 2002, 97, 3-24
14. Rao, D. N. R.; Mason, R. P. Generation of Nitro Radical Anions of Some 5-Nitrofurans, 2-Nitrofurans and 5-Nitroimidazoles by Norepinephrine, Dopamine, and Serotonin-A Possible Mechanism for Neurotoxicity Caused by Nitroheterocyclic Drugs J. Biol. Chem. 1987, 262, 11731-11736
15. Dubuisson, M. L. N.; De Wergifosse, B.; Kremers, P.; Marchand-Brynaert, J.; Trouet, A.; Rees, J. F. Protection against nitrofurantoin-induced oxidative stress by coelenterazine analogues and their oxidation products in rat hepatocytes Free Radical Res. 2001, 34, 285-296
16. Rao, D. N.; Harman, L.; Motten, A.; Schreiber, J.; Mason, R. P. Generation of radical anions of nitrofurantoin, misonidazole, and metronidazole by ascorbate Arch. Biochem. Biophys. 1987, 255, 419-427
17. Zhou, L.; Ishizaki, H.; Spitzer, M.; Taylor, K. L.; Temperley, N. D.; Johnson, S. L.; Brear, P.; Gautier, P.; Zeng, Z.; Mitchell, A.; Narayan, V.; McNeil, E. M.; Melton, D. W.; Smith, T. K.; Tyers, M.; Westwood, N. J.; Patton, E. E. ALDH2 Mediates 5-Nitrofuran Activity in Multiple Species Chem. Biol. 2012, 19, 883-892
18. Bock, M.; Mayer, K. H.; Herlinge., H.; Haberkor., A.; Petersen, S. Structure-Activity Relationship of 4-(5′-Nitrofurfurylidene-amino)- tetrahydro-4 h -1,4-thiazine-1,1-dioxides Active against Trypanosoma cruzi Arzneim. Forsch. 1972, 22, 1564-1569
19. Mester, B. E., J.; Claramunt, R. M.; Castanys, S.; Mascaro, M. L.; Osuna, A.; Vilaplana, M. J.; Molina, P. Activity against Trypanosoma cruzi of the new analogs of nifurtimox Arch. Pharm. 1987, 320, 115-120
20. Caracelli, I.; Stamato, F. M. L. G.; Mester, B.; Paulino, M.; Cerecetto, H. A new analogue of nifurtimox Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 1996, 52, 1281-1282
21. Pozas, R.; Carballo, J.; Castro, C.; Rubio, J. Synthesis and in vitro antitrypanosomal activity of novel Nifurtimox analogues Bioorg. Med. Chem. Lett. 2005, 15, 1417-1421
22. Arancibia, R.; Klahn, A. H.; Buono-Core, G. E.; Gutierrez-Puebla, E.; Monge, A.; Medina, M. E.; Olea-Azar, C.; Maya, J. D.; Godoy, F. Synthesis, characterization and anti- Trypanosoma cruzi evaluation of ferrocenyl and cyrhetrenyl imines derived from 5-nitrofurane J. Organomet. Chem. 2011, 696, 3238-3244
23. Aguirre, G.; Boiani, L.; Cerecetto, H.; Fernandez, M.; Gonzalez, M.; Denicola, A.; Otero, L.; Gambino, D.; Rigol, C.; Olea-Azar, C.; Faundez, M. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones Bioorg. Med. Chem. 2004, 12, 4885-4893
24. Hall, B. S.; Wu, X.; Hu, L.; Wilkinson, S. R. Exploiting the drug-activating properties of a novel trypanosomal nitroreductase Antimicrob. Agents Chemother. 2010, 54, 1193-1199
25. Bot, C.; Hall, B. S.; Bashir, N.; Taylor, M. C.; Helsby, N. A.; Wilkinson, S. R. Trypanocidal activity of aziridinyl nitrobenzamide prodrugs Antimicrob. Agents Chemother. 2010, 54, 4246-4252
26. Hu, L. Q.; Wu, X. H.; Han, J. Y.; Chen, L.; Vass, S. O.; Browne, P.; Hall, B. S.; Bot, C.; Gobalakrishnapillai, V.; Searle, P. F.; Knox, R. J.; Wilkinson, S. R. Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs Bioorg. Med. Chem. Lett. 2011, 21, 3986-3991
27. Tangallapally, R. P.; Yendapally, R.; Lee, R. E.; Hevener, K.; Jones, V. C.; Lenaerts, A. J. M.; McNeil, M. R.; Wang, Y. H.; Franzblau, S.; Lee, R. E. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents J. Med. Chem. 2004, 47, 5276-5283
28. Gupta, R. A.; Gupta, A. K.; Soni, L. K.; Kaskhedikar, S. G. Exploration of physicochemical properties and molecular modeling studies of furanylamide analogs as antituberculosis agents QSAR Comb. Sci. 2007, 26, 897-907
29. De La Fuente, R.; D Sonawane, N.; Arumainayagam, D.; Verkman, A. S. Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening Br. J. Pharmacol. 2006, 149, 551-559
30. Tawari, N. R.; Degani, M. S. Pharmacophore Mapping and Electronic Feature Analysis for a Series of Nitroaromatic Compounds with Antitubercular Activity J. Comput. Chem. 2010, 31, 739-751
31. Ancizu, S.; Moreno, E.; Torres, E.; Burguete, A.; Perez-Silanes, S.; Benitez, D.; Villar, R.; Solano, B.; Marin, A.; Aldana, I.; Cerecetto, H.; Gonzalez, M.; Monge, A. Heterocyclic-2-carboxylic Acid (3-Cyano-1,4-di- N -oxidequinoxalin-2-yl)amide Derivatives as Hits for the Development of Neglected Disease Drugs Molecules 2009, 14, 2256-2272
32. Ebringer, L. J., A.; Krkoska, P.; Kada, R.; Foltinova, P. New nitrofurans. Correlation study between chemical structures and biological activity. Advances in Antimicrobial and Antineoplastic Chemotherapy: Progress in Research and Clinical Application: pt 1-2. Antimicrobial Chemotherapy; Volume 1, Part 1, of Advances in Antimicrobial and Antineoplastic Chemotherapy: Progress in Research and Clinical Application: Proceedings: Proceedings of the VIIth International Congress of Chemotherapy, Prague, 1971; University Park Press: Ann Arbor, MI, 1972; pp 873-876.
33. Bock, M.; Haberkorn, A.; Herlinger, H.; Mayer, K. H.; Petersen, S. The structure-activity relationship of 4-(5′-nitrofurfurylidene-amino)- tetrahydro-4 H -1,4-thiazine-1,1-dioxides active against Trypanosoma cruzi Arzneim. Forsch. 1972, 22, 1564-1569
34. Byler, K. G.; Brito-Arias, M.; Marquez-Navarro, A.; Nogueda-Torres, B.; Torres-Bustillos, L. G.; Martinez-Mayorga, K. Identification of benzoylisoquinolines as potential anti-Chagas agents Bioorg. Med. Chem. 2012, 20, 2587-2594
35. Millet, R.; Maes, L.; Landry, V.; Sergheraert, C.; Davioud-Charvet, E. Antitrypanosomal activities and cytotoxicity of 5-nitro-2-furancarbohydrazides Bioorg. Med. Chem. Lett. 2002, 12, 3601-3604
36. Karl Gewald, E. S.; Böttcher, H. Heterocyclen aus CH-aciden Nitrilen, VIII. 2-Amino-thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und Schwefel Chem. Ber. 1966, 99, 94-100
37. Hesse, S.; Perspicace, E.; Kirsch, G. Microwave-assisted synthesis of 2-aminothiophene-3-carboxylic acid derivatives, 3 H -thieno[2,3- d ]pyrimidin-4-one and 4-chlorothieno[2,3- d ]pyrimidine Tetrahedron Lett. 2007, 48, 5261-5264
38. Kim, J.; Chang, S. Ammonium salts as an inexpensive and convenient nitrogen source in the Cu-catalyzed amination of aryl halides at room temperature Chem. Commun. 2008, 3052-3054
39. Sakai, T. T.; Santi, D. V. Hydrolysis of hydroxybenzotrifluorides and fluorinated uracil derivatives. A general mechanism for carbon-fluorine bond labilization J. Med. Chem. 1973, 16, 1079-1084
40. Thompson, D. C.; Perera, K.; London, R. Spontaneous hydrolysis of 4-trifluoromethylphenol to a quinone methide and subsequent protein alkylation Chem. Biol. Interact. 2000, 126, 1-14
41. Mikus, J.; Steverding, D. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue Parasitol. Int. 2000, 48, 265-269
42. Martin, K. L.; Smith, T. K. The glycosylphosphatidylinositol (GPI) biosynthetic pathway of bloodstream-form Trypanosoma brucei is dependent on the de novo synthesis of inositol Mol. Microbiol. 2006, 61 (1) 89-105
43. Baliani, A.; Bueno, G. J.; Stewart, M. L.; Yardley, V.; Brun, R.; Barrett, M. P.; Gilbert, I. H. Design and Synthesis of a Series of Melamine-Based Nitroheterocycles with Activity against Trypanosomatid Parasites J. Med. Chem. 2005, 48 (17) 5570-5579